Zealand licenses Vyteris’ transdermal patch
The drive to license needle-free delivery methods continues with Zealand Pharma signing a deal to use its peptide optimisation technology with Vyteris’ controlled transdermal patch.
The drive to license needle-free delivery methods continues with Zealand Pharma signing a deal to use its peptide optimisation technology with Vyteris’ controlled transdermal patch.
Companies seeking research services in India and China will now be able to use a single contact following an alliance between GVK BIO and Excel, which the companies claim is the first to span the two nations.
US contractor MeadWestvaco (MWV) claims the latest addition to its Shellpack range, the Shellpak-170, offers drugmakers more options for adherence promotion blister packaging.
Although the downturn has slowed Big Pharma’s investment in China, the country’s wide ranging healthcare reforms and changing economic landscape still provide considerable opportunities says PricewaterhouseCoopers (PwC).
Massachusetts Biotechnology Council’s (MBC) 2015 strategic plan has outlined the difficulties the state faces in attracting biomanufacturing and called for increased focus on R&D.
Germany’s XClinical says 2008 was a successful year with a 20 per cent hike in revenues for its electronic data capture (EDC) and clinical data/trial management (CDM/CTM) software.
Merck Serono, the small molecules development division of Germany’s Merck KGaA, will use Aegis Analytical’s Discoverant data management and analytics platform at its manufacturing facility in Vevey Switzerland.